3.54
price up icon1.14%   0.04
after-market After Hours: 3.57 0.03 +0.85%
loading
Calcimedica Inc stock is traded at $3.54, with a volume of 104.82K. It is up +1.14% in the last 24 hours and down -18.78% over the past month. CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
See More
Previous Close:
$3.50
Open:
$3.54
24h Volume:
104.82K
Relative Volume:
2.25
Market Cap:
$38.06M
Revenue:
-
Net Income/Loss:
$-34.36M
P/E Ratio:
-0.099
EPS:
-35.74
Net Cash Flow:
$-25.81M
1W Performance:
-9.92%
1M Performance:
-18.78%
6M Performance:
-38.33%
1Y Performance:
+24.21%
1-Day Range:
Value
$3.45
$3.69
1-Week Range:
Value
$3.45
$5.65
52-Week Range:
Value
$2.68
$8.38

Calcimedica Inc Stock (CALC) Company Profile

Name
Name
Calcimedica Inc
Name
Phone
858-952-5500
Name
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Name
Employee
13
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
CALC's Discussions on Twitter

Calcimedica Inc Stock (CALC) Latest News

pulisher
02:55 AM

H.C. Wainwright cuts CalciMedica stock target to $16, keeps Buy rating - Investing.com Canada

02:55 AM
pulisher
Nov 02, 2024

Graybug Vision Suspends Stock Offering Amid Proposed Public Offering of CalciMedica - Defense World

Nov 02, 2024
pulisher
Nov 01, 2024

Calcimedica director Robert Wilson acquires $199,998 in stock - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Calcimedica director Robert Wilson acquires $199,998 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Director Robert Wilson Acquires 53,333 Shares of CalciMedica Inc (CALC) - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica CEO Rachel Leheny acquires $75,000 in common stock - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

CalciMedica CEO Rachel Leheny acquires $75,000 in common stock By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Oct 31, 2024

CalciMedica announces proposed public offering of common stock - MSN

Oct 31, 2024
pulisher
Oct 30, 2024

CalciMedica Announces Pricing of Public Offering of Common Stock - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica launches public stock offering - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica launches public stock offering By Investing.com - Investing.com UK

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica Announces Proposed Public Offering of Common Stock - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica, Inc. (NASDAQ:CALC) Sees Significant Decline in Short Interest - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica’s Promising Phase 2b Trial Results for Auxora - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - PR Newswire

Oct 30, 2024
pulisher
Oct 28, 2024

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - Citizentribune

Oct 28, 2024
pulisher
Oct 26, 2024

Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN

Oct 26, 2024
pulisher
Oct 22, 2024

CalciMedica (NASDAQ:CALC) Stock Price Up 1% – Here’s What Happened - Defense World

Oct 22, 2024
pulisher
Oct 16, 2024

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - StockTitan

Oct 16, 2024
pulisher
Sep 30, 2024

Scientech Research LLC Buys New Position in Grand Canyon Education, Inc. (NASDAQ:LOPE) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Kenvue Inc. (NYSE:KVUE) Shares Bought by Brandes Investment Partners LP - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Regal Investment Advisors LLC Has $7.19 Million Holdings in AT&T Inc. (NYSE:T) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

LandBridge (NYSE:LB) and Texas Pacific Land (NYSE:TPL) Financial Comparison - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Baozun Inc. (NASDAQ:BZUN) Short Interest Update - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

CalciMedica, Inc. (NASDAQ:CALC) Short Interest Up 5.1% in September - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Likewise Group (LON:LIKE) Stock Price Up 3.1% Following Dividend Announcement - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Senator Investment Group LP Acquires New Position in CleanSpark, Inc. (NASDAQ:CLSK) - Defense World

Sep 30, 2024
pulisher
Sep 29, 2024

Evergreen Capital Management LLC Takes Position in IAC Inc. (NASDAQ:IAC) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

Caxton Associates LP Sells 4,741 Shares of Verizon Communications Inc. (NYSE:VZ) - Defense World

Sep 28, 2024
pulisher
Sep 27, 2024

Regencell Bioscience (NASDAQ:RGC) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 27, 2024

Acute Pancreatitis Market Business Insights, Key Trend Analysis - Economica

Sep 27, 2024
pulisher
Sep 25, 2024

CalciMedica (NASDAQ:CALC) Shares Down 2% - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

CalciMedica (NASDAQ:CALC) Trading Down 2% - Defense World

Sep 24, 2024
pulisher
Sep 20, 2024

Allegiant Travel (NASDAQ:ALGT) Issues Q3 2024 Earnings Guidance - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Milan stock market opens weak, luxury retraces, cues on doValue, down Lottomatica after Abb - Marketscreener.com

Sep 20, 2024
pulisher
Sep 19, 2024

Poseida Therapeutics Garners FDA RMAT Designation for Allogeneic CAR-T P-BCMA-ALLO1 in R/R Multiple Myeloma - CGTLive™

Sep 19, 2024
pulisher
Sep 19, 2024

Allete takeover will get a recommendation from Minnesota PUC's ALJ by July 15 - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

CAH Stock Sees Decline of Approximately -1.71% in Last Five Days - Knox Daily

Sep 19, 2024
pulisher
Sep 18, 2024

Will CARPO Data Propel CalciMedica Stock? - RTTNews

Sep 18, 2024
pulisher
Sep 16, 2024

Cardinal Health Inc. stock rises Monday, still underperforms market - MarketWatch

Sep 16, 2024
pulisher
Sep 16, 2024

Insight Health Systems of Flint plans to purchase ProMedica Coldwater Regional Hospital - Coldwater Daily Reporter

Sep 16, 2024
pulisher
Sep 16, 2024

Forsta AP Fonden Acquires 11,900 Shares of Allegion plc (NYSE:ALLE) - Defense World

Sep 16, 2024
pulisher
Sep 16, 2024

11,237 Shares in Allegion plc (NYSE:ALLE) Acquired by Acadian Asset Management LLC - Defense World

Sep 16, 2024
pulisher
Sep 15, 2024

Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Gap Down to $16.58 - Defense World

Sep 15, 2024
pulisher
Sep 11, 2024

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald

Sep 11, 2024
pulisher
Sep 09, 2024

CalciMedica And 2 Other Penny Stocks Insiders Are Buying - MSN

Sep 09, 2024
pulisher
Sep 05, 2024

CalciMedica Inc [CALC] Shares Jump Approximately 60.20% Over the Year - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

CalciMedica, Inc. (NASDAQ:CALC) Short Interest Down 6.5% in August - Defense World

Sep 02, 2024
pulisher
Aug 27, 2024

CalciMedica CEO acquires $4,189 in stock at $4.20-$4.27 range - Investing.com

Aug 27, 2024

Calcimedica Inc Stock (CALC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):